Lonza has confirmed it is on track to meet its 2009 financial goals. Chief executive, Stefan Borgas, said the company saw robust underlying demand in life science markets remains and an increased outsourcing in biopharma as well as in chemical APIs, but that Lonza was feeling the effect of customer supply chain optimisation.
In addition, Lonza has started-up its high-titre 2000L microbial manufacturing train in Hopkinton, MA. The train is complemented by a highly flexible purification area. Lonza has also revamped the entire Hopkinton site infrastructure.
Reuters
Lonza
Thursday 23 April 2009
Lonza on target; opens 2000L facility
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment